HSBC Holdings
THRD

HSBC Holdings’s Third Harmonic Bio THRD Stock Holding History

HSBC Holdings’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,758
Closed -$151K – 3125
2025
Q2 		$151K Buy
27,758
+2,111
+8% +$10.5K ﹤0.01% 2764
2025
Q1 		$88.5K Buy
25,647
+9,272
+57% +$45K ﹤0.01% 2834
2024
Q4 		$169K Buy
16,375
+5,186
+46% +$64.6K ﹤0.01% 2766
2024
Q3 		$154K Sell
11,189
-68
-0.6% -$842 ﹤0.01% 2706
2024
Q2 		$144K Sell
11,257
-720
-6% -$8.91K ﹤0.01% 2654
2024
Q1 		$113K Buy
+11,977
New +$116K ﹤0.01% 2821

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HSBC Holdings's THRD Position: Q3 2025 in Review

HSBC Holdings sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 27,758 shares — an estimated $151K sold.

HSBC Holdings first reported a position in THRD in Q1 2024 and held it in 6 quarters. The position peaked at $169K in Q4 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • HSBC Holdings reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 27,758 Third Harmonic Bio shares in Q3 2025, an estimated $151K.
  • HSBC Holdings first reported a position in Third Harmonic Bio in Q1 2024 and held it in 6 quarters.
  • HSBC Holdings's Third Harmonic Bio position peaked at $169K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.